This finding suggested that DAB2IP played a crucial role in counteracting the oncogenic influences of tRF‐34‐P4R8YP9LON4VHM, highlighting its potential as a regulatory factor in the progression of HCC. This evidence concerns the gene DAB2IP and hepatocellular carcinoma.